“This study highlights that previously undetected maternal cancers can provide a biologic explanation for noninvasive prenatal screening results that are discordant from prenatal diagnostic tests. Although maternal cancer during pregnancy is rare, it is important for providers and patients to be aware that abnormal screening results can have implications for the fetus and the mother, ” said Dr. Vora, who is also the director of reproductive genetics at UNC-Chapel Hill.